BUSINESS DEVELOPMENT
TRACK RECORD
We are a proven partner for success having prepared and facilitated high profile M&A and business development transactions, with many of them having been top ranked among the leading European and global deals.
In the following you will find a select list of deal references.
BENCHMARK - U3 PHARMA - DAIICHI SANKYO
The success of a business development process very much depends on the personal credibility, professional quality and scientific as well as commercia. excellence of our transaction partners. In this respect Irina and her team have been crucial to the completion of our acquisition of U3 Pharma.
DICK VAN DUYNE, SENIOR ADVISOR
(former Head of Global Business Development)
DAICHI SANKYO, CO. LTD
BENCHMARK - EUROPEAN BIOTECH FIRM - MITSUBISHI TANABE
Since we have known each other, Irina has been consistently impressive in her ability to build cases, design BD strategies and appropriately implement them. Among the European Biotech community she is one of the few BD consultants with a solid track record of significant achievements. As investors, we never hesitate to invite our portfolio companies to check her out.
GILLES NOBÉCOURT
PARTNER AT EDMOND DE ROTHSCHILD INVESTMENT PARTNERS
BENCHMARK - EUROPEAN BIOTECH FIRM - ALLERGAN
BENCHMARK - EUROPEAN BIOTECH COMPANY - MERCK & CO
Kebomed Europe secures license to distribute Womed Leaf®
April 9th, 2025
Womed licensed Womed Leaf® to Saesco Medical
April 9th, 2025
Transaction Advisor to Allecra Therapeutics GmbH
June 24, 2024
Transaction Advisor to Lallemand Pharma
March 20, 2024
Transaction Advisor to Retinagix Holdings, LLC
January 19, 2022
Transaction Advisor to Allecra Therapeutics GmbH
January 13, 2022
Transaction Advisor to GamaMabs Pharma SA
May 04, 2021
Transaction Advisor to Allecra Therapeutics GmbH
December 21, 2020
Transaction Advisor to German Cancer Research Center (DKFZ)
September 14, 2020
Transaction Advisor to Sapiotec GmbH
January 20, 2020